Bio-Techne Q1 FY27: where the revenue came from and where it went
The whole income statement of Bio-Techne for this quarter, as one diagram: what earned the revenue, and what it went on.
- Period
- Jul 1 – Sep 30, 2026
- Reported
- Nov 6, 2026
Revenue$0.30B
+5% year over year
Gross profit$0.20B
66% margin
Operating profit$0.04B
12% margin
Net profit$0.03B
9% margin
The numbers
| Item | Value | Share of revenue | Year over year |
|---|---|---|---|
| Revenue | 0.30 | 100% | +5% |
| Consumables | 0.24 | 79% | +2% |
| Instruments | 0.03 | 9% | +17% |
| Services | 0.02 | 7% | −18% |
| Royalty | 0.01 | 5% | +157% |
| Cost of revenue | −0.10 | 34% | |
| Gross profit | 0.20 | 66% margin | +0pp |
| SG&A | −0.13 | 45% | +4pp |
| Other | −0.03 | 8% | +0pp |
| Operating profit | 0.04 | 12% margin | −4pp |
| Tax | −0.01 | ||
| Net profit | 0.03 | 9% margin | −4pp |
6 of 418 companies, most recently reported first
New results in your inbox
When a big company reports, we send you a link to its diagram before anyone has time to comment on it. This is a mailing list, not an account: it does not open the diagrams by itself. No spam, one-click unsubscribe.
Drag or use the arrow keys to see the rest